News Quantified

VRCA – verrica pharmaceuticals inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.

Verrica Pharmaceuticals, Inc. (VRCA) Q4 2024 Earnings Conference Call Transcript [Seeking Alpha]

Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]

Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025

-7.6%

BEAT

-7.6%

BEAT

-7.6%

BEAT

-7.6%

BEAT

Needham & Company LLC

Needham & Company LLC

Form S-3 Verrica Pharmaceuticals

Form 10-K Verrica Pharmaceuticals For: Dec 31

Form 8-K Verrica Pharmaceuticals For: Mar 11

Form 8-K Verrica Pharmaceuticals For: Feb 18

Form SCHEDULE 13G Verrica Pharmaceuticals Filed by: ARMISTICE CAPITAL, LLC

Top News Gainers

3/23 Verrica Pharmaceuticals Inc (NASDAQ: VRCA) is now covered by analysts at Needham & Company LLC. They set a "buy" rating on the stock. 33.8%

3/17 Verrica Pharmaceuticals Inc (NASDAQ: VRCA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 22.8%

3/19 Verrica Pharmaceuticals Inc (NASDAQ: VRCA) had its "buy" rating re-affirmed by analysts at HC Wainwright. 22.5%

6/27 Verrica Pharmaceuticals Enrolls First Patient in Phase 2 Trial of VP-102 for the Treatment of External Genital Warts 20.0%

6/6 Form 4 Verrica Pharmaceuticals For: Jun 04 Filed by: Davidson Matt 12.6%

9/9 Form 4 Verrica Pharmaceuticals For: Sep 05 Filed by: Davidson Matt 12.5%

3/13 Q4/2019 12/31/2019 EPS -0.310 ZacksConsensus -0.300 ActVsEst (0.010) - Miss 12.2%

6/12 Form 8-K Verrica Pharmaceuticals For: Jun 12 10.5%

7/8 Form 4 Verrica Pharmaceuticals For: Jul 03 Filed by: Davidson Matt 9.5%

11/25 Verrica Pharmaceuticals Announces Participation in the Piper Jaffray 31st Annual Healthcare Conference 8.5%

Top News Decliners

3/13 Form 8-K Verrica Pharmaceuticals For: Mar 10 -21.6%

10/18 Form 8-K Verrica Pharmaceuticals For: Oct 18 -12.3%

6/27 Form 8-K Verrica Pharmaceuticals For: Jun 26 -11.2%

8/1 Form 4 Verrica Pharmaceuticals For: Jul 30 Filed by: Davidson Matt -10.0%

11/27 Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum -9.8%

10/21 Form 4 Verrica Pharmaceuticals For: Oct 18 Filed by: DAVIS A BRIAN -7.3%

7/1 Form 8-K Verrica Pharmaceuticals For: Jul 01 -5.6%

8/9 Form 4 Verrica Pharmaceuticals For: Aug 07 Filed by: Davidson Matt -5.3%

7/29 Form 4 Verrica Pharmaceuticals For: Jul 25 Filed by: Davidson Matt -5.1%

3/27 Verrica Pharmaceuticals Inc (NASDAQ: VRCA) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -4.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day